Loading clinical trials...
Loading clinical trials...
The trial proposed is a single arm phase II treatment protocol designed to examine engraftment, toxicity, graft-versus-host disease, and ultimate disease-free survival following a novel cytoreductive ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical College of Wisconsin
Collaborators
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT03579875 · Fanconi Anemia, Severe Aplastic Anemia, and more
NCT04784052 · Fanconi Anemia
NCT04232085 · Primary Immune Deficiency Disorder, Immune Deficiency Disease, and more
NCT02143830 · Fanconi Anemia, Severe Marrow Failure, and more
Medical College of Wisconsin
Milwaukee, Wisconsin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions